Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02548546 · ClinicalTrials.gov registry record · NA

Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques

A NA study of Abdominal Aortic Aneurysm, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT02548546: Recruiting NA study of Abdominal Aortic Aneurysm, sponsored by Mayo Clinic.

NCT02548546 is a NA study of Abdominal Aortic Aneurysm that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 452-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02548546, a NA study of Abdominal Aortic Aneurysm, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this study is to establish the practicality of using two novel imaging modalities for the assessment of biomechanical properties of the aorta.

Primary Outcome

Imaging taken of the aneurysm, locating peak wall stress and measuring percent of strain per seconds.

Conditions Studied

Interventions

  • DEVICE ECHO
  • DEVICE ECG-gated MRA

Study Locations (1)

Florida

  • Mayo Clinic Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2015-08
Est. Completion 2026-08
Phase NA
Mayo Clinic

2,844 total trials

What NCT02548546 shows while recruiting

NCT02548546 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 452-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 2 interventions - of which ECHO is the first listed.

NCT02548546 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT02548546 about?

NCT02548546 is a clinical study titled "Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques". The primary aim of this study is to establish the practicality of using two novel imaging modalities for the assessment of biomechanical properties of the aorta.

What is the current status of trial NCT02548546?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2015-08. Estimated completion is 2026-08.

What conditions does trial NCT02548546 study?

This clinical trial studies the following conditions: Abdominal Aortic Aneurysm.

What interventions are being tested in trial NCT02548546?

The interventions under investigation include: ECHO (DEVICE), ECG-gated MRA (DEVICE).

Who is sponsoring clinical trial NCT02548546?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02548546 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abdominal Aortic Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02548546's enrollment target sits among peer trials

30 13th of 16 higher than 4 of 16 other Abdominal Aortic Aneurysm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Abdominal Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02548546, the US trial registry maintained by the National Library of Medicine. NCT02548546 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.